Live Breaking News & Updates on Centauri Therapeutics Limited

Stay updated with breaking news from Centauri therapeutics limited. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Centauri Therapeutics Limited: Centauri Therapeutics Strengthens Senior Leadership Team With Three Key Appointments

Dr Jennifer Schneider appointed CEO, Dr Helen Bright joins as VP of Research Development, and Professor David Roblin will Chair the Board of Directors Senior appointments support acceleration ....

United States , Pamela Brown , Michelle Ricketts , Sosei Heptares , Jennifer Schneider , Mike Westby , Kostenloser Wertpapierhandel , David Roblin Frcp Fmedsci , David Roblin , Global Antibiotic Research Development Partnership , Impact Fund , Research Development , Boehringer Ingelheim Venture Fund , University Of Michigan , Centauri Therapeutics Limited , University Of Notre Dame , Master Of Public Health In Epidemiology , Zyme Communications , Professor Of Medicine At Swansea University , Newcastle Upon Tyne University , International Health , Francis Crick Institute , Novo Holdings , Professor David Roblin , Therapeutics Limited , Chief Executive Officer ,

Centauri Therapeutics Limited: Centauri Therapeutics Closes £24 Million GBP Series A Investment Round

Investment from Boehringer Ingelheim Venture Fund, Evotec SE, and Novo Holdings REPAIR Impact Fund Funding will support continued advancement of Centauri's antimicrobial resistance research ....

Johannes Zanzinger , Mike Westby , Sebastian Kreuz , Kostenloser Wertpapierhandel , Camilla Petrycer Hansen , Michelle Ricketts , Camilla Petrycer , Centauri Therapeutics Limited , Animatrix Founders , Zyme Communications , Impact Fund , Boehringer Ingelheim Venture Fund , Kent Life Science , Novo Holdings , Karen Lackey , Therapeutics Limited , Chief Scientific Officer , Centauri Therapeutics , Investment Director , Board Observer , Global Head , Integrated Drug Discovery , Resistance Collaborators ,

Boehringer Ingelheim Venture Fund GmbH, Novo Holdings REPAIR Impact Fund and Evotec SE complete lead Series A investment in Centauri Therapeutics Limited

Boehringer Ingelheim Venture Fund GmbH, Novo Holdings REPAIR Impact Fund and Evotec SE complete lead Series A investment in Centauri Therapeutics Limited ....

Rheinland Pfalz , United Kingdom , City Of , Kenny Walker Durrant , Tim Worden , Sophie Mcgrath , Anjlee Sakaria , Heidi Fitchett , Lucy Sharples , Curtis Mccluskey , Megan Gibson , Cambridge Life Sciences , Boehringer Ingelheim Corporation , Impact Fund Novo , Infective Resistance Impact Fund , Boehringer Ingelheim Venture Fund Gmb , Novo Nordisk Foundation , Centauri Therapeutics Limited , Novo Holdings , Boehringer Ingelheim Venture Fund Gmbh , Centauri Therapeutic , Boehringer Ingelheim , Novo Nordisk , Anti Infective Resistance , Impact Fund , Georgia Powell ,